Magenta Therapeutics Inc.

NASDAQ: MGTA · Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM

Magenta Therapeutics Revenue

Magenta Therapeutics reported an annual revenue of $6.24M, reflecting a 0% growth. For the quarter ending March 31, 2025, Magenta Therapeutics generated $1.16M in revenue.
Revenue (ttm)
6.24M
Revenue Growth
n/a
Price / Sales Ratio
0.44
Revenue / Employee
93.06K
Employees
67
Market Cap
42.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 6.24M +Infinity%
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.